Streetbeat News

Stock Prices

SNDL

SNDL Inc. reported a 1.6% YoY drop in Q2 revenue due to softness in the liquor segment, while cannabis operations showed strong growth. The company achieved a record gross margin of 25.5% and significantly reduced its net loss. SNDL also announced a restructuring project expected to save over CA$20 million annually.

Portfolio Pulse from Nina Zdinjak

August 02, 2024 | 12:51 pm

Nu Holdings shares are trading lower after UBS downgraded the stock from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:50 pm

AAPL

AMZN

META

MSFT

SPY

A Benzinga poll reveals that over 70% of investors believe the stock market has not yet peaked in 2024, with expectations of new highs by year-end. The SPDR S&P 500 ETF Trust (SPY) is up 18.4% year-to-date. Earnings reports from Apple (AAPL), Amazon (AMZN), Meta Platforms (META), and Microsoft (MSFT) showed mixed results, with Amazon missing net sales estimates but beating EPS expectations. Historical trends suggest a challenging August and September for the S&P 500.

Portfolio Pulse from Chris Katje

August 02, 2024 | 12:47 pm

ADAP

GLPG

The FDA has approved Adaptimmune Therapeutics' (NASDAQ:ADAP) Tecelra for treating unresectable or metastatic synovial sarcoma, marking the first engineered cell therapy for solid tumors in the U.S. and the first new therapy for this rare cancer in over a decade. The approval is based on the SPEARHEAD-1 trial results, showing a 43% overall response rate. Adaptimmune plans to establish multiple treatment centers. Additionally, Adaptimmune has entered a collaboration with Galapagos NV (NASDAQ:GLPG) for future TCR T-cell therapies.

Portfolio Pulse from Vandana Singh

August 02, 2024 | 12:46 pm

MCHP

Microchip Technology (NASDAQ:MCHP) reported mixed Q1 results, beating earnings estimates but missing revenue expectations. The company provided a cautious Q2 outlook, leading to a 5% drop in share price. Analysts from B of A Securities, Susquehanna, and JP Morgan lowered their price targets.

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:46 pm

NXT

Nextracker shares are trading lower following the company's Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:44 pm

TWST

Twist Bioscience shares are trading lower following the company's Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:43 pm

DAR

TALO

VCNX

The article highlights notable insider trades in Talos Energy, Vaccinex, and Darling Ingredients, indicating potential confidence in these companies' prospects. Insider purchases can signal a buying opportunity.

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:43 pm

LUMN

TSM

TYL

WFC

Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round.' He recommended buying Wells Fargo (WFC) and praised Tyler Technologies (TYL) for its stellar reputation. He acknowledged the political risk in Taiwan Semiconductor (TSM) but noted it is a great company. Cramer expressed no conviction in Cemex (CX) and suggested caution with Lumen Technologies (LUMN) despite its recent price increase.

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:42 pm

FLR

Fluor Corp (NYSE:FLR) reported mixed Q2 results with revenue growth of 7.3% YoY to $4.227 billion, missing the consensus of $4.360 billion. Adjusted EPS improved to $0.85, beating the consensus of $0.68. The company reaffirmed its 2024 adjusted EPS guidance of $2.50 to $3.00 and tightened its adjusted EBITDA guidance to $625 million – $675 million. FLR shares are trading lower by 0.99% premarket.

Portfolio Pulse from Akanksha Bakshi

August 02, 2024 | 12:39 pm